Lifeward (LFWD) Net Cash Flow Growth (1y) (2016 - 2026)
Lifeward (LFWD) Net Cash Flow Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | 76.43% |
| 10 | Lifeward | 11.56 Mn | 137,830.56 | 1.34 Mn | 1,000.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.39% |
| Dec 31, 2025 | 106.07% |
| Sep 30, 2025 | 27.02% |
| Jun 30, 2025 | 89.34% |
| Mar 31, 2025 | 86.62% |
| Dec 31, 2024 | 13.02% |
| Sep 30, 2024 | 82.53% |
| Jun 30, 2024 | -50.95% |
| Mar 31, 2024 | -27.80% |
| Dec 31, 2023 | 26.76% |
| Sep 30, 2023 | -432.67% |
| Jun 30, 2023 | -1.00% |
| Mar 31, 2023 | -5.13% |
| Dec 31, 2022 | -116.24% |
| Sep 30, 2022 | -117.75% |
| Jun 30, 2022 | -16.25% |
| Mar 31, 2022 | -112.14% |
| Dec 31, 2021 | -224.29% |
| Sep 30, 2021 | 576.66% |
| Jun 30, 2021 | -22.59% |